SEC Form 4 · accession 0001209191-16-088677
Alaunos Therapeutics, Inc. · TCRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Weiser
Director
Period of report
Dec 31, 2015
Accepted (ET)
Jan 5, 2016 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 31, 2015 | F | 2,047 | $8.31 | D | 164,887 | D | |
| Common StockF2 | Dec 31, 2015 | A | 26,661 | $0.00 | A | 191,548 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld to satisfy withholding tax obligations upon the vesting of a restricted stock grant.
- F226,661 shares shall vest on 12/31/2016.